We are live on
!
Find out more
PFM
Privium Fund Management Portfolio holdings
AUM
$480M
1-Year Est. Return
77.45%
This Fund
S&P 500
This Quarter
Est. Return
+10.91%
1 Year Est. Return
+77.45%
3 Year Est. Return
+410.34%
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$392M
AUM Growth
+$17.6M
(+4.7%)
Cap. Flow
+$3.68M
Cap. Flow
% of AUM
0.94%
Top 10 Holdings %
Top 10 Hldgs %
60.17%
Holding
139
New
22
Increased
37
Reduced
35
Closed
10
Top Buys
| 1 |
Tesla
TSLA
|
+$7.69M |
| 2 |
ALX Oncology
ALXO
|
+$4.88M |
| 3 |
Advanced Micro Devices
AMD
|
+$4.75M |
| 4 |
Ultragenyx Pharmaceutical
RARE
|
+$1.56M |
| 5 |
ASTSW
AST SpaceMobile, Inc. Warrant
ASTSW
|
+$1.51M |
Top Sells
| 1 |
Spotify
SPOT
|
+$6.02M |
| 2 |
FUSN
Fusion Pharmaceuticals Inc. Common Shares
FUSN
|
+$5.35M |
| 3 |
Alphabet (Google) Class A
GOOGL
|
+$3.37M |
| 4 |
Protagonist Therapeutics
PTGX
|
+$3.3M |
| 5 |
Moderna
MRNA
|
+$2.1M |
Sector Composition
| 1 | Consumer Discretionary | 24.59% |
| 2 | Healthcare | 24.36% |
| 3 | Technology | 24.32% |
| 4 | Communication Services | 14.32% |
| 5 | Materials | 0.81% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
26
Coupang
CPNG
$31.6B
| $4.24M | 1.08% |
201,900
+5,000
| +3% | +$108K |
|
27
Zai Lab
ZLAB
$2.19B
| $3.75M | 0.96% |
215,789
-24,894
| -10% | -$438K |
|
|
ASTSW
28
DELISTED
AST SpaceMobile, Inc. Warrant
ASTSW
| $3.71M | 0.95% |
+1,034,275
| New | +$1.51M |
|
|
29
Moderna
MRNA
$26.7B
| $2.72M | 0.69% |
23,261
-16,600
| -42% | -$2.1M |
|
30
uniQure
QURE
$2.89B
| $2.57M | 0.66% |
640,416
+61,501
| +11% | +$299K |
|
31
Acadia Pharmaceuticals
ACAD
$4.36B
| $2.35M | 0.6% |
148,400
| – | – |
|
|
32
ALX Oncology
ALXO
$260M
| $2.27M | 0.58% |
+396,966
| New | +$4.88M |
|
33
HEICO Corp Class A
HEI.A
$35B
| $2.11M | 0.54% |
11,865
| – | – |
|
|
GRND.WS
34
DELISTED
Grindr Inc. Warrants, each exercisable for one share of Common Stock at an exercise price of $11.50 per share
GRND.WS
| $2.03M | 0.52% |
701,118
+98,788
| +16% | +$220K |
|
|
CLBTW
35
DELISTED
Cellebrite DI Ltd. Warrants
CLBTW
| $1.81M | 0.46% |
643,948
-5,479
| -0.8% | -$12.9K |
|
|
SMR.WS
36
DELISTED
NuScale Power Corporation Warrants, each exercisable for one share of Class A Common Stock at an exercise price of $11.50 per share
SMR.WS
| $1.71M | 0.43% |
690,449
+243,476
| +54% | +$316K |
|
37
Biogen
BIIB
$28.8B
| $1.6M | 0.41% |
7,000
-160
| -2% | -$34.8K |
|
38
Under Armour
UAA
$2.82B
| $1.46M | 0.37% |
226,200
+3,300
| +1% | +$22.5K |
|
39
CRISPR Therapeutics
CRSP
$5B
| $1.45M | 0.37% |
27,347
+14,600
| +115% | +$845K |
|
40
Ambev
ABEV
$47.9B
| $1.31M | 0.33% |
635,914
+176,672
| +38% | +$402K |
|
41
Krystal Biotech
KRYS
$10.1B
| $1.14M | 0.29% |
6,420
+1,920
| +43% | +$322K |
|
42
Brown-Forman Class B
BF.B
$11.6B
| $1.1M | 0.28% |
25,800
| – | – |
|
43
Pfizer
PFE
$138B
| $1.01M | 0.26% |
36,120
+6,960
| +24% | +$192K |
|
44
Fox Class B
FOX
$20.8B
| $998K | 0.25% |
30,900
| – | – |
|
|
IMTXW
45
DELISTED
Immatics N.V. Warrants
IMTXW
| $902K | 0.23% |
295,814
+45,231
| +18% | +$127K |
|
|
RNAM
46
DELISTED
Avidity Biosciences
RNAM
| $863K | 0.22% |
22,242
+14,200
| +177% | +$407K |
|
47
4D Molecular Therapeutics
FDMT
$613M
| $823K | 0.21% |
40,000
+9,000
| +29% | +$226K |
|
48
Citigroup
C
$227B
| $807K | 0.21% |
12,478
-2,100
| -14% | -$129K |
|
49
MeiraGTx Holdings
MGTX
$1.17B
| $804K | 0.21% |
203,960
+83,975
| +70% | +$424K |
|
50
NOV
NOV
$6.85B
| $734K | 0.19% |
39,719
-4,900
| -11% | -$91.8K |
|
Similar funds
FCM
DA
YLHM
BFA
HC
LIM
TAA
NQWM